Status: Recruiting
A Phase 2 Study of YA-101 in Patients With Multiple System Atrophy
This is a Phase 2, double-blind, placebo-controlled, multi-center, Phase II, dose escalation study to evaluate the safety, tolerability, pharmacokinetics and efficacy of Ya-101 in subjects with multiple system atrophy.
Participants needed: 75
Trial details
Phase: Phase 2Age: 30+Biological sex: AllType: InterventionalSponsor: Dasher Neuroscience Inc.Updated: Apr 29, 2026Locations: 9
Eligibility criteria
Able to understand the process of the clinical trial and give informed consent f... [+4]
Positive urine test for drugs of abuse and/or alcohol test both at screening and... [+4]